a form of nuclear imaging which uses fluorodeoxyglucose (FDG) as the radiotracer.
This allows a 3D image of metabolic activity to be generated using glucose uptake as a proxy marker. The images obtained are then combined with a conventional imaging technique such as CT to decide whether lesions are metabolically active.
Uses evaluating primary and possible metastatic disease cardiac PET: not used mainstream currently